These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3233010)

  • 21. [Cystic fibrosis: current therapy. Antibiotics].
    Tamm M; Héritier F; Rappaz I; Schaad UB
    Schweiz Med Wochenschr Suppl; 2000; 122():33S-37S. PubMed ID: 12536469
    [No Abstract]   [Full Text] [Related]  

  • 22. "Pull-through" method for silastic catheter insertion.
    Kerlan RK; Pogany AC; Ring EJ
    AJR Am J Roentgenol; 1984 Jan; 142(1):103-4. PubMed ID: 6606940
    [No Abstract]   [Full Text] [Related]  

  • 23. The use and abuse of antibiotics, including in management of pulmonary manifestations in cystic fibrosis.
    Kulczycki LL; Wientzen R
    Monogr Paediatr; 1979; 10():27-30. PubMed ID: 460274
    [No Abstract]   [Full Text] [Related]  

  • 24. Endovascular port-a-cath insertion in a patient with cystic fibrosis and occluded superior vena cava.
    Ali A; Zayed H; Wilkins J; Wyatt H; Rashid H
    Vasc Endovascular Surg; 2009; 43(3):280-3. PubMed ID: 19164301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complications of peripherally inserted central catheters in adults with cystic fibrosis or bronchiectasis.
    Dupont C; Gouya H; Panzo R; Hubert D; Correas JM; Agrario L; Chapron J; Honoré I; Kanaan R; Legmann P; Dusser D; Vignaux O; Burgel PR
    J Vasc Access; 2015; 16(3):245-9. PubMed ID: 25656251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuous intravenous β-lactam antibiotics in cystic fibrosis patients with severe drug hypersensitivity.
    Breuer O; Cohen-Cymberknoh M; Armoni S; Kerem E; Shoseyov D
    Ann Allergy Asthma Immunol; 2014 Aug; 113(2):229-30. PubMed ID: 24934107
    [No Abstract]   [Full Text] [Related]  

  • 27. Dry powder inhalation versus wet nebulisation delivery of antibiotics in cystic fibrosis patients.
    Westerman EM; Heijerman HG; Frijlink HW
    Expert Opin Drug Deliv; 2007 Mar; 4(2):91-4. PubMed ID: 17335406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhaled aminoglycosides in cystic fibrosis.
    Jew LL; Hart LL
    DICP; 1990; 24(7-8):711-2. PubMed ID: 2197811
    [No Abstract]   [Full Text] [Related]  

  • 29. Antibiotic dosage in cystic fibrosis.
    Lancet; 1985 May; 1(8436):1020-1. PubMed ID: 2859469
    [No Abstract]   [Full Text] [Related]  

  • 30. Aerosol antibiotic treatment in cystic fibrosis.
    Littlewood JM; Smye SW; Cunliffe H
    Arch Dis Child; 1993 Jun; 68(6):788-92. PubMed ID: 8333776
    [No Abstract]   [Full Text] [Related]  

  • 31. The use of 8-cm 22G Seldinger catheters for intravenous access in children with cystic fibrosis.
    Qian SY; Horn MT; Barnes R; Armstrong D
    J Vasc Access; 2014; 15(5):415-7. PubMed ID: 25041922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous long-lines in children with cystic fibrosis: a multidisciplinary approach.
    Turner MA; Unsworth V; David TJ
    J R Soc Med; 2002; 95 Suppl 41(Suppl 41):11-21. PubMed ID: 12216269
    [No Abstract]   [Full Text] [Related]  

  • 33. The long arm silastic catheter: a critical look at complications.
    Prian GW; Van Way CW
    JPEN J Parenter Enteral Nutr; 1978 May; 2(2):124-8. PubMed ID: 121752
    [No Abstract]   [Full Text] [Related]  

  • 34. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
    Smyth AR; Tan KH
    Cochrane Database Syst Rev; 2006 Jul; (3):CD002009. PubMed ID: 16855982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nebulised anti-pseudomonal antibiotics for cystic fibrosis.
    Ryan G; Mukhopadhyay S; Singh M
    Cochrane Database Syst Rev; 2000; (2):CD001021. PubMed ID: 10796732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cystic Fibrosis Frequently Asked Questions: Question 4: What is the appropriate duration of therapy for respiratory exacerbations in Cystic Fibrosis patients infected with Pseudomonas aeruginosa?
    Sutton KM; Fitzgerald DA
    Paediatr Respir Rev; 2016 Jan; 17():60-2. PubMed ID: 25982382
    [No Abstract]   [Full Text] [Related]  

  • 37. [Antibiotic inhalation in cystic fibrosis. A review of the literature].
    Steinkamp G
    Monatsschr Kinderheilkd; 1991 Feb; 139(2):73-80. PubMed ID: 1903843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Percutaneous-peripheral vena cava catheterization in intensive care of premature and newborn infants. Comparison of Shaw's silastic catheter with the customary polyvinyl catheter].
    Müller WD; Trittenwein G; Stein J; Schober P
    Anaesthesist; 1983 Nov; 32(11):545-7. PubMed ID: 6660478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypersensitivity reactions to intravenous antibiotics in cystic fibrosis.
    Wright MFA; Bush A; Carr SB
    Paediatr Respir Rev; 2018 Jun; 27():9-12. PubMed ID: 29703693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nebuliser systems for drug delivery in cystic fibrosis.
    Daniels T; Mills N; Whitaker P
    Paediatr Respir Rev; 2013 Jun; 14(2):98-9. PubMed ID: 23583049
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.